AQR Capital Management’s Celldex Therapeutics CLDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-21,724
| Closed | -$549K | – | 3160 |
|
|
2024
Q4 | $549K | Sell |
21,724
-3,619
| -14% | -$91.5K | ﹤0.01% | 2204 |
|
|
2024
Q3 | $861K | Buy |
25,343
+17,486
| +223% | +$594K | ﹤0.01% | 1916 |
|
|
2024
Q2 | $291K | Buy |
7,857
+1,504
| +24% | +$55.7K | ﹤0.01% | 2282 |
|
|
2024
Q1 | $267K | Buy |
+6,353
| New | +$267K | ﹤0.01% | 2167 |
|
|
2023
Q3 | – | Sell |
-6,835
| Closed | -$232K | – | 2324 |
|
|
2023
Q2 | $232K | Buy |
6,835
+5
| +0.1% | +$170 | ﹤0.01% | 2037 |
|
|
2023
Q1 | $246K | Sell |
6,830
-1,738
| -20% | -$62.5K | ﹤0.01% | 1999 |
|
|
2022
Q4 | $382K | Sell |
8,568
-660
| -7% | -$29.4K | ﹤0.01% | 1908 |
|
|
2022
Q3 | $259K | Sell |
9,228
-232
| -2% | -$6.51K | ﹤0.01% | 1983 |
|
|
2022
Q2 | $255K | Hold |
9,460
| – | – | ﹤0.01% | 1916 |
|
|
2022
Q1 | $322K | Hold |
9,460
| – | – | ﹤0.01% | 1949 |
|
|
2021
Q4 | $366K | Sell |
9,460
-1,392
| -13% | -$53.9K | ﹤0.01% | 1924 |
|
|
2021
Q3 | $586K | Buy |
+10,852
| New | +$586K | ﹤0.01% | 1805 |
|
|
2016
Q1 | – | Sell |
-2,220
| Closed | -$523K | – | 2224 |
|
|
2015
Q4 | $523K | Sell |
2,220
-3,717
| -63% | -$876K | ﹤0.01% | 1857 |
|
|
2015
Q3 | $939K | Sell |
5,937
-1,656
| -22% | -$262K | ﹤0.01% | 1466 |
|
|
2015
Q2 | $2.87M | Buy |
7,593
+4,215
| +125% | +$1.59M | 0.01% | 1031 |
|
|
2015
Q1 | $1.41M | Buy |
3,378
+527
| +18% | +$220K | ﹤0.01% | 1266 |
|
|
2014
Q4 | $781K | Buy |
2,851
+364
| +15% | +$99.7K | ﹤0.01% | 1760 |
|
|
2014
Q3 | $483K | Sell |
2,487
-4,560
| -65% | -$886K | ﹤0.01% | 1950 |
|
|
2014
Q2 | $1.73M | Buy |
7,047
+4,137
| +142% | +$1.01M | ﹤0.01% | 1371 |
|
|
2014
Q1 | $771K | Sell |
2,910
-3,986
| -58% | -$1.06M | ﹤0.01% | 1818 |
|
|
2013
Q4 | $2.5M | Buy |
6,896
+2,515
| +57% | +$913K | 0.01% | 1221 |
|
|
2013
Q3 | $2.33M | Sell |
4,381
-1,120
| -20% | -$595K | 0.01% | 1196 |
|
|
2013
Q2 | $1.29M | Buy |
+5,501
| New | +$1.29M | ﹤0.01% | 1443 |
|